全球防脱髮药物市场－产业规模、份额、趋势、机会和预测，按类型（产品、药物）、性别、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球防脱髮药物市场规模为28.9亿美元，预计到2030年将以8.55%的复合年增长率增长至47.3亿美元。该市场涵盖了旨在缓解脱髮、促进头髮生长并治疗斑秃等疾病的药物製剂和外用製剂，以及各种医疗程序。市场扩张的主要驱动力是全球不同人群脱髮盛行率的不断上升，以及人口老化加剧，老年人更容易受到此类问题的困扰。消费者对现有治疗方法的认知度提高以及对美观的日益重视也进一步促进了市场成长。

主要市场驱动因素

脱髮疾病日益普遍，从根本上推动了全球防脱髮药物市场的需求。诸如雄性秃和斑秃等疾病影响着相当一部分人群，促使人们积极寻求有效的治疗方案。

主要市场挑战

假性脱髮治疗产品的氾滥严重阻碍了全球防脱髮药物市场的扩张。这些非法产品通常含有未经批准或有害的成分，直接危害消费者健康，而且往往没有任何治疗效果。

主要市场趋势

生物疗法和再生疗法的出现标誌着抗脱髮药物市场发生了重大变革，其治疗重点不再局限于症状缓解，而是转向解决潜在的细胞机制。这些先进疗法，包括干细胞疗法和基因疗法，着重于再生毛囊并恢復头髮的自然生长週期。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球防脱髮药物市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（产品、药品）
  • 按性别（男，女）
  • 依最终使用者分类（皮肤科医院和诊所、家庭护理机构、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美防脱髮药物市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲防脱髮药物市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区防脱髮药物市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲防脱髮药物市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲防脱髮药物市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球防脱髮药物市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Sun Pharmaceutical Industries Ltd.
• Histogen Inc.
• Aclaris Therapeutics, Inc.
• Coegin Pharma AB

第十六章：策略建议

第17章调查会社について・免责事项

The Global Anti-Hair Loss Medicine Market, valued at USD 2.89 Billion in 2024, is projected to experience a CAGR of 8.55% to reach USD 4.73 Billion by 2030. The Global Anti-Hair Loss Medicine Market comprises pharmaceutical and topical formulations, alongside various medical procedures, engineered to mitigate hair fall, stimulate regrowth, and address conditions such as alopecia. Market expansion is primarily propelled by the increasing global prevalence of hair loss across diverse demographics, alongside a burgeoning aging population inherently more susceptible to such concerns. Heightened consumer awareness regarding available treatment modalities and a strong emphasis on aesthetic well-being further contribute to this growth.

Key Market Drivers

The increasing prevalence of hair loss disorders fundamentally drives demand within the global anti-hair loss medicine market. Conditions such as androgenetic alopecia and alopecia areata affect a substantial portion of the population, leading individuals to actively seek effective treatment solutions. According to the National Council on Aging, in April 2025, "30 Interesting Hair Loss Statistics - National Council on Aging", 85% of men and 33% of women will experience some form of hair loss during their lifetimes, underscoring the widespread nature of this concern.

Key Market Challenges

The pervasive issue of counterfeit hair loss treatments poses a significant impediment to the expansion of the Global Anti-Hair Loss Medicine Market. These illicit products frequently contain unapproved or harmful ingredients, directly endangering consumer health and often providing no therapeutic benefit. Such instances compromise patient safety, leading to adverse reactions or ineffective outcomes that erode public confidence in all hair loss solutions.

Key Market Trends

The emergence of biologic and regenerative therapies marks a significant evolution in the anti-hair loss medicine market, moving beyond symptomatic treatments to address underlying cellular mechanisms. These advanced approaches, including stem cell and gene therapies, focus on regenerating hair follicles and restoring natural growth cycles. According to the International Society of Hair Restoration Surgery, in 2024, 84.7% of surgical hair restoration procedures were performed on male patients, compared to 15.3% on female patients, indicating a substantial patient pool seeking effective solutions across genders.

Key Market Players

• Merck & Co., Inc.
• Johnson & Johnson Services, Inc.
• Dr. Reddy's Laboratories Ltd.
• Cipla Limited
• Sun Pharmaceutical Industries Ltd.
• Histogen Inc.
• Aclaris Therapeutics, Inc.
• Coegin Pharma AB

Report Scope:

In this report, the Global Anti-Hair Loss Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Anti-Hair Loss Medicine Market, By Type:

• Product
• Medicine

Anti-Hair Loss Medicine Market, By Gender:

• Male
• Female

Anti-Hair Loss Medicine Market, By End user:

• Dermatology hospitals and clinics
• Home Care Setting
• Others

Anti-Hair Loss Medicine Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Anti-Hair Loss Medicine Market.

Available Customizations:

Global Anti-Hair Loss Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Anti-Hair Loss Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Product, Medicine)
  • 5.2.2. By Gender (Male, Female)
  • 5.2.3. By End user (Dermatology hospitals and clinics, Home Care Setting, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Anti-Hair Loss Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Gender
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Anti-Hair Loss Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Gender
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Anti-Hair Loss Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Gender
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Anti-Hair Loss Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Gender
      • 6.3.3.2.3. By End user

7. Europe Anti-Hair Loss Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Gender
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Anti-Hair Loss Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Gender
      • 7.3.1.2.3. By End user
  • 7.3.2. France Anti-Hair Loss Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Gender
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Anti-Hair Loss Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Gender
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Anti-Hair Loss Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Gender
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Anti-Hair Loss Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Gender
      • 7.3.5.2.3. By End user

8. Asia Pacific Anti-Hair Loss Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Gender
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Anti-Hair Loss Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Gender
      • 8.3.1.2.3. By End user
  • 8.3.2. India Anti-Hair Loss Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Gender
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Anti-Hair Loss Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Gender
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Anti-Hair Loss Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Gender
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Anti-Hair Loss Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Gender
      • 8.3.5.2.3. By End user

9. Middle East & Africa Anti-Hair Loss Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Gender
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Anti-Hair Loss Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Gender
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Anti-Hair Loss Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Gender
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Anti-Hair Loss Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Gender
      • 9.3.3.2.3. By End user

10. South America Anti-Hair Loss Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Gender
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Anti-Hair Loss Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Gender
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Anti-Hair Loss Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Gender
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Anti-Hair Loss Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Gender
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Anti-Hair Loss Medicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Merck & Co., Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Johnson & Johnson Services, Inc.
• 15.3. Dr. Reddy's Laboratories Ltd.
• 15.4. Cipla Limited
• 15.5. Sun Pharmaceutical Industries Ltd.
• 15.6. Histogen Inc.
• 15.7. Aclaris Therapeutics, Inc.
• 15.8. Coegin Pharma AB

16. Strategic Recommendations

17. About Us & Disclaimer